The results of western blot analysis showed that the expression of HAX-1 at protein level in Hep-2-CSCs was obviously higher than that in the Hep-2-non-CSCs and paracancerous tissues of LCC (Figure 5B). This evidence concerns the gene HAX1 and leukoencephalopathy with calcifications and cysts.